Abstract
In recent years, dietary agents such as isoflavone genistein, curcumin, indole-3-carbinol (I3C), 3,3’-diindolylmethane (DIM), (-)-epigallocatechin-3-gallate (EGCG), resveratrol, and lycopene have received increased attention as anti-cancer agents. There has been a growing interest in investigating the effects of these dietary agents known as nutraceuticals on the inhibition of cancer cell growth in combination with chemotherapeutics or radiotherapy. The results from pre-clinical in vitro and in vivo experimental studies have demonstrated that the anti-cancer effects of chemotherapeutics and radiotherapy could be enhanced by combination treatment with nutraceuticals. Experimental evidence have also shown that the enhanced anti-cancer effects of nutraceuticals could in part due to deregulation of NF-κB, Akt, MDR, COX-2, AR, MAPK, and apoptotic signaling pathways that are known to play critical roles in cell survival and therapeutic resistance. In this chapter, we are summarizing the current evidence from pre-clinical and clinical trials demonstrating the effects and the molecular mechanisms of nutraceutical intervention in combination treatments, and we believe that this information would allow researcher to have a fresh look at the potential value of nutraceutical in cancer therapy.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Aggarwal BB, Kumar A, Bharti AC (2003) Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 23:363–398
Ahmad IU, Forman JD, Sarkar FH et al (2010) Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer. Nutr Cancer 62:996–1000
Akimoto T, Nonaka T, Ishikawa H et al (2001) Genistein, a tyrosine kinase inhibitor, enhanced radiosensitivity in human esophageal cancer cell lines in vitro: possible involvement of inhibition of survival signal transduction pathways. Int J Radiat Oncol Biol Phys 50:195–201
Ali S, Ahmad A, Banerjee S et al (2010a) Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. Cancer Res 70:3606–3617
Ali S, Banerjee S, Schaffert JM et al (2010b) Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer. J Cell Biochem 110:171–181
Alvero AB, O’Malley D, Brown D et al (2006) Molecular mechanism of phenoxodiol-induced apoptosis in ovarian carcinoma cells. Cancer 106:599–608
Banerjee S, Zhang Y, Ali S et al (2005) Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Cancer Res 65:9064–9072
Banerjee S, Zhang Y, Wang Z et al (2007) In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer. Int J Cancer 120:906–917
Bao B, Ali S, Kong D et al (2011) Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer. PLoS One 6:e17850
Bava SV, Puliappadamba VT, Deepti A et al (2005) Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-kappaB and the serine/threonine kinase Akt and is independent of tubulin polymerization. J Biol Chem 280:6301–6308
Bhardwaj A, Sethi G, Vadhan-Raj S et al (2007) Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood 109:2293–2302
Bhatnagar N, Li X, Chen Y et al (2009) 3,3'-diindolylmethane enhances the efficacy of butyrate in colon cancer prevention through down-regulation of survivin. Cancer Prev Res (Phila) 2: 581–589
Bishayee A (2009) Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials. Cancer Prev Res (Phila) 2:409–418
Busby MG, Jeffcoat AR, Bloedon LT et al (2002) Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men. Am J Clin Nutr 75:126–136
Cabrespine-Faugeras A, Bayet-Robert M, Bay JO et al (2010) Possible benefits of curcumin regimen in combination with taxane chemotherapy for hormone-refractory prostate cancer treatment. Nutr Cancer 62:148–153
Chan MM, Fong D, Soprano KJ et al (2003) Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents. J Cell Physiol 194:63–70
Chen TC, Wang W, Golden EB et al (2011) Green tea epigallocatechin gallate enhances therapeutic efficacy of temozolomide in orthotopic mouse glioblastoma models. Cancer Lett 302:100–108
Chendil D, Ranga RS, Meigooni D et al (2004) Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 23:1599–607
Chisholm K, Bray BJ, Rosengren RJ (2004) Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells. Anticancer Drugs 15:889–97
Choueiri TK, Wesolowski R, Mekhail TM (2006) Phenoxodiol: isoflavone analog with antineoplastic activity. Curr Oncol Rep 8:104–107
Chuang SE, Yeh PY, Lu YS et al (2002) Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells. Biochem Pharmacol 63:1709–1716
Colin D, Gimazane A, Lizard G et al (2009) Effects of resveratrol analogs on cell cycle progression, cell cycle associated proteins and 5fluoro-uracil sensitivity in human derived colon cancer cells. Int J Cancer 124:2780–2788
Constantinou AI, Mehta R, Husband A (2003) Phenoxodiol, a novel isoflavone derivative, inhibits dimethylbenz[a]anthracene (DMBA)-induced mammary carcinogenesis in female Sprague-Dawley rats. Eur J Cancer 39:1012–1018
Cover CM, Hsieh SJ, Cram EJ et al (1999) Indole-3-carbinol and tamoxifen cooperate to arrest the cell cycle of MCF-7 human breast cancer cells. Cancer Res 59:1244–1251
Davenport A, Frezza M, Shen M et al (2010) Celastrol and an EGCG pro-drug exhibit potent chemosensitizing activity in human leukemia cells. Int J Mol Med 25:465–470
Deeb D, Xu YX, Jiang H et al (2003) Curcumin (diferuloyl-methane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells. Mol Cancer Ther 2:95–103
El-Rayes BF, Ali S, Ali IF et al (2006) Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB. Cancer Res 66:10553–10559
Epelbaum R, Schaffer M, Vizel B et al (2010) Curcumin and gemcitabine in patients with advanced pancreatic cancer. Nutr Cancer 62:1137–1141
Fischer L, Mahoney C, Jeffcoat AR et al (2004a) Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia. Nutr Cancer 48:160–170
Fischer L, Mahoney C, Jeffcoat AR et al (2004b) Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia. Nutr Cancer 48:160–170
Grainger EM, Schwartz SJ, Wang S et al (2008) A combination of tomato and soy products for men with recurring prostate cancer and rising prostate specific antigen. Nutr Cancer 60:145–154
Harikumar KB, Kunnumakkara AB, Sethi G et al (2010) Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. Int J Cancer 127:257–268
Heath EI, Heilbrun LK, Li J et al (2010) A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer. Am J Transl Res 2:402–411
Hillman GG, Singh-Gupta V (2011) Soy isoflavones sensitize cancer cells to radiotherapy. Free Radic Biol Med 51:289–298
Hillman GG, Forman JD, Kucuk O et al (2001) Genistein potentiates the radiation effect on prostate carcinoma cells. Clin Cancer Res 7:382–390
Hillman GG, Wang Y, Kucuk O et al (2004) Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model. Mol Cancer Ther 3:1271–1279
Hwang JT, Ha J, Park OJ (2005) Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways. Biochem Biophys Res Commun 332:433–440
Ichite N, Chougule MB, Jackson T et al (2009) Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer. Clin Cancer Res 15:543–552
Ivanov VN, Partridge MA, Johnson GE et al (2008) Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression. Exp Cell Res 314:1163–1176
Javvadi P, Segan AT, Tuttle SW et al (2008) The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway. Mol Pharmacol 73: 1491–1501
Jazirehi AR, Bonavida B (2004) Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin’s lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. Mol Cancer Ther 3:71–84
Jemal A, Siegel R, Xu J et al (2010) Cancer statistics, 2010. CA Cancer J Clin 60:277–300
Jian L, Lee AH, Binns CW (2007) Tea and lycopene protect against prostate cancer. Asia Pac J Clin Nutr 16(Suppl 1):453–457
Johnson GE, Ivanov VN, Hei TK (2008) Radiosensitization of melanoma cells through combined inhibition of protein regulators of cell survival. Apoptosis 13:790–802
Kamat AM, Tharakan ST, Sung B et al (2009) Curcumin potentiates the antitumor effects of Bacillus Calmette-Guerin against bladder cancer through the downregulation of NF-kappaB and upregulation of TRAIL receptors. Cancer Res 69:8958–8966
Kamsteeg M, Rutherford T, Sapi E et al (2003) Phenoxodiol–an isoflavone analog–induces apoptosis in chemoresistant ovarian cancer cells. Oncogene 22:2611–2620
Kang HJ, Lee SH, Price JE et al (2009) Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model. Breast J 15:223–229
Kao CL, Huang PI, Tsai PH et al (2009) Resveratrol-induced apoptosis and increased radiosensitivity in CD133-positive cells derived from atypical teratoid/rhabdoid tumor. Int J Radiat Oncol Biol Phys 74:219–228
Khoshyomn S, Manske GC, Lew SM et al (2000) Synergistic action of genistein and cisplatin on growth inhibition and cytotoxicity of human medulloblastoma cells. Pediatr Neurosurg 33:123–131
Khoshyomn S, Nathan D, Manske GC et al (2002) Synergistic effect of genistein and BCNU on growth inhibition and cytotoxicity of glioblastoma cells. J Neurooncol 57:193–200
Kucuk O, Sarkar FH, Sakr W et al (2001) Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 10:861–868
Kucuk O, Sarkar FH, Djuric Z et al (2002) Effects of lycopene supplementation in patients with localized prostate cancer. Exp Biol Med (Maywood) 227:881–885
Kumar NB, Cantor A, Allen K et al (2004) The specific role of isoflavones in reducing prostate cancer risk. Prostate 59:141–147
Kumar NB, Krischer JP, Allen K et al (2007) A Phase II randomized, placebo-controlled clinical trial of purified isoflavones in modulating steroid hormones in men diagnosed with localized prostate cancer. Nutr Cancer 59:163–168
Kumar NB, Besterman-Dahan K, Kang L et al (2008) Results of a Randomized Clinical Trial of the Action of Several Doses of Lycopene in Localized Prostate Cancer: Administration Prior to Radical Prostatectomy. Clin Med Urol 1:1–14
Kunnumakkara AB, Guha S, Krishnan S et al (2007) Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res 67:3853–3861
Kunnumakkara AB, Diagaradjane P, Anand P et al (2009) Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model. Int J Cancer 125:2187–2197
Kweon SH, Song JH, Kim TS (2010) Resveratrol-mediated reversal of doxorubicin resistance in acute myeloid leukemia cells via downregulation of MRP1 expression. Biochem Biophys Res Commun 395:104–110
Lee R, Kim YJ, Lee YJ et al (2004) The selective effect of genistein on the toxicity of bleomycin in normal lymphocytes and HL-60 cells. Toxicology 195:87–95
Lev-Ari S, Strier L, Kazanov D et al (2005) Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clin Cancer Res 11:6738–6744
Lev-Ari S, Vexler A, Starr A et al (2007) Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines. Cancer Invest 25:411–418
Li N, Chen X, Liao J et al (2002) Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis 23:1307–1313
Li Y, Ellis KL, Ali S et al (2004) Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line. Pancreas 28:e90–e95
Li Y, Ahmed F, Ali S et al (2005) Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Res 65:6934–6942
Li Y, Kucuk O, Hussain M et al (2006) Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer. Cancer Res 66:4816–4825
Li Y, Wang Z, Kong D et al (2007) Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells. J Biol Chem 282:21542–21550
Li Y, Wang Z, Kong D et al (2008) Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells. J Biol Chem 283:27707–27716
Li Y, Revalde JL, Reid G et al (2011a) Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells. Cancer Chemother Pharmacol 68:603–610. Epub 2010
Li Y, Kong D, Wang Z et al (2011b) Inactivation of AR/TMPRSS2-ERG/Wnt signaling networks attenuates the aggressive behavior of prostate cancer cells. Cancer Prev Res (Phila) 4:1495–1506
Liang G, Tang A, Lin X et al (2010) Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer. Int J Oncol 37:111–123
Lin YW, Tsai MS, Weng SH et al (2011) Synergistic effect of curcumin and cisplatin via downregulation of thymidine phosphorylase and ERCC1. Mol Pharmacol 80:136–146
Lu KH, Chen YW, Tsai PH et al (2009) Evaluation of radiotherapy effect in resveratrol-treated medulloblastoma cancer stem-like cells. Childs Nerv Syst 25:543–550
Luo T, Wang J, Yin Y et al (2010) (-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma. Breast Cancer Res 12:R8
Ma Y, Wang J, Liu L et al (2011) Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-kappaB. Cancer Lett 301:75–84
McGuire KP, Ngoubilly N, Neavyn M et al (2006) 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells. J Surg Res 132:208–213
Messina MJ, Persky V, Setchell KD et al (1994) Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 21:113–131
Mohammad RM, Al-Katib A, Aboukameel A et al (2003) Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy. Mol Cancer Ther 2:1361–1368
Nakachi K, Matsuyama S, Miyake S et al (2000) Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 13:49–54
Nakamura K, Yasunaga Y, Segawa T et al (2002) Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines. Int J Oncol 21:825–830
Nihal M, Ahmad N, Mukhtar H et al (2005) Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma. Int J Cancer 114:513–521
Nihal M, Ahsan H, Siddiqui IA et al (2009) (-)-Epigallocatechin-3-gallate (EGCG) sensitizes melanoma cells to interferon induced growth inhibition in a mouse model of human melanoma. Cell Cycle 8:2057–2063
Notarbartolo M, Poma P, Perri D et al (2005) Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. Cancer Lett 224:53–65
Padhye S, Banerjee S, Chavan D et al (2009a) Fluorocurcumins as cyclooxygenase-2 inhibitor: molecular docking, pharmacokinetics and tissue distribution in mice. Pharm Res 26:2438–2445
Padhye S, Yang H, Jamadar A et al (2009b) New difluoro Knoevenagel condensates of curcumin, their Schiff bases and copper complexes as proteasome inhibitors and apoptosis inducers in cancer cells. Pharm Res 26:1874–1880
Patel BB, Sengupta R, Qazi S et al (2008) Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R. Int J Cancer 122:267–273
Pereira MA, Grubbs CJ, Barnes LH et al (1996) Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Carcinogenesis 17:1305–1311
Raffoul JJ, Wang Y, Kucuk O et al (2006) Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC Cancer 6:107
Raffoul JJ, Banerjee S, Che M et al (2007a) Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model. Int J Cancer 120:2491–2498
Raffoul JJ, Banerjee S, Singh-Gupta V et al (2007b) Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo. Cancer Res 67:2141–149
Rahman KM, Banerjee S, Ali S et al (2009) 3,3'-Diindolylmethane enhances taxotere-induced apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation. Cancer Res 69:4468–4475
Sapi E, Alvero AB, Chen W et al (2004) Resistance of ovarian carcinoma cells to docetaxel is XIAP dependent and reversible by phenoxodiol. Oncol Res 14:567–578
Sarkar FH, Li Y (2004) Indole-3-carbinol and prostate cancer. J Nutr 134:3493S–348S
Sarkar FH, Li Y (2006) Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Res 66:3347–3350
Sarkar FH, Li Y, Wang Z et al (2010) The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer. Cancer Metastasis Rev 29:383–394
Satoh H, Nishikawa K, Suzuki K et al (2003) Genistein, a soy isoflavone, enhances necrotic-like cell death in a breast cancer cell treated with a chemotherapeutic agent. Res Commun Mol Pathol Pharmacol 113–114:149–158
Scarlatti F, Sala G, Ricci C et al (2007) Resveratrol sensitization of DU145 prostate cancer cells to ionizing radiation is associated to ceramide increase. Cancer Lett 253:124–130
Shamim U, Hanif S, Albanyan A et al (2011) Resveratrol-induced apoptosis is enhanced in low pH environments associated with cancer. J Cell Physiol (Epub ahead of print)
Shankar S, Ganapathy S, Chen Q et al (2008) Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis. Mol Cancer 7:16
Shervington A, Pawar V, Menon S et al (2009) The sensitization of glioma cells to cisplatin and tamoxifen by the use of catechin. Mol Biol Rep 36:1181–1186
Shiau RJ, Chen KY, Wen YD et al (2010) Genistein and beta-carotene enhance the growth-inhibitory effect of trichostatin A in A549 cells. Eur J Nutr 49:19–25
Shukla S, Zaher H, Hartz A et al (2009) Curcumin inhibits the activity of ABCG2/BCRP1, a multidrug resistance-linked ABC drug transporter in mice. Pharm Res 26:480–487
Siddiqui IA, Malik A, Adhami VM et al (2008) Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene 27:2055–2063
Singh-Gupta V, Joiner MC, Runyan L et al (2011) Soy isoflavones augment radiation effect by inhibiting APE1/Ref-1 DNA repair activity in non-small cell lung Cancer. J Thorac Oncol 6:688–698
Sreekanth CN, Bava SV, Sreekumar E et al (2011) Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer. Oncogene 30:3139–3152
Stearns ME, Amatangelo MD, Varma D et al (2010) Combination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: inhibition of metastatic tumor growth in severe combined immunodeficiency mice. Am J Pathol 177:3169–3179
Surh YJ (2003) Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3:768–780
Takimoto CH, Glover K, Huang X et al (2003) Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer. Cancer Epidemiol Biomarkers Prev 12:1213–1221
Taniguchi S, Fujiki H, Kobayashi H et al (1992) Effect of (-)-epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines. Cancer Lett 65:51–54
Vaishampayan U, Hussain M, Banerjee M et al (2007) Lycopene and soy isoflavones in the treatment of prostate cancer. Nutr Cancer 59:1–7
Wang J, He D, Zhang Q et al (2009) Resveratrol protects against Cisplatin-induced cardiotoxicity by alleviating oxidative damage. Cancer Biother Radiopharm 24:675–680
Yashar CM, Spanos WJ, Taylor DD et al (2005) Potentiation of the radiation effect with genistein in cervical cancer cells. Gynecol Oncol 99:199–205
Zhang Q, Wei D, Liu J (2004) In vivo reversal of doxorubicin resistance by (-)-epigallocatechin gallate in a solid human carcinoma xenograft. Cancer Lett 208:179–186
Acknowledgements
The authors’ work cited in this review article was funded by grants from the National Cancer Institute, NIH (5R01CA083695, 5R01CA108535, 5R01CA132794, and 5R01CA131151 awarded to FHS). We also thank Puschelberg and Guido foundations for their generous contribution to support our research.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Li, Y., Kong, D., Ahmad, A., Bao, B., Sarkar, F.H. (2012). Augmenting the Efficacy of Chemo- and Radio-Therapy by Nutraceuticals: Evidence from Pre-clinical and Clinical Trials. In: Sarkar, F. (eds) Nutraceuticals and Cancer. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-2630-7_16
Download citation
DOI: https://doi.org/10.1007/978-94-007-2630-7_16
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-2629-1
Online ISBN: 978-94-007-2630-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)